1-Thieno[3,2-d]pyrimidin-4-ylpiperidine-4-carbaldehyde; 97%; 250mg; F.W.: 247.31; C12H13N3OS; M.P.: 94-95; Primary CAS: 916766-91-1
-
P/N:
CC63804CB
- UOM: EA
- UOM Qty: 1
|
|
1-Thieno[3,2-d]pyrimidin-4-ylpiperidine-4-carboxylic acid; 97%; 5g; F.W. 263.31; C12H13N3O2S; M.P. 247.5-249deg.C; Primary CAS: 910037-25-1
-
P/N:
CC63801DE
- UOM: EA
- UOM Qty: 1
|
|
1-Thieno[3,2-d]pyrimidin-4-ylpiperidine-4-carboxylic acid; 97%; 1g; F.W. 263.31; C12H13N3O2S; M.P. 247.5-249deg.C; Primary CAS: 910037-25-1
-
P/N:
CC63801DA
- UOM: EA
- UOM Qty: 1
|
|
4,4,5,5-Tetramethyl-2-[3-(phenoxymethyl)phenyl]-1,3,2-dioxaborolane; 97+%; 1g; F.W. 310.20; C19H23BO3; M.P. 76.5-77.5deg.C; Primary CAS: 912569-68-7
-
P/N:
CC63639DA
- UOM: EA
- UOM Qty: 1
|
|
4,4,5,5-Tetramethyl-2-[3-(phenoxymethyl)phenyl]-1,3,2-dioxaborolane; 97+%; 250mg; F.W. 310.20; C19H23BO3; M.P. 76.5-77.5deg.C; Primary CAS: 912569-68-7
-
P/N:
CC63639CB
- UOM: EA
- UOM Qty: 1
|
|
5-Amino-1-methyl-2-oxoindoline; 97%; 1g; F.W.: 162.19; C9H10N2O; M.P.: 109-111.5; Primary CAS: 20870-91-1
-
P/N:
CC63014DA
- UOM: EA
- UOM Qty: 1
|
|
5-Amino-1-methyl-2-oxoindoline; 97%; 250mg; F.W.: 162.19; C9H10N2O; M.P.: 109-111.5; Primary CAS: 20870-91-1
-
P/N:
CC63014CB
- UOM: EA
- UOM Qty: 1
|
|
Pentafluorophenyl 2-morpholino-1,3-thiazole-4-carboxylate; 97%; 1g; F.W.: 380.29; C14H9F5N2O3S; M.P.: 118-119.5; Primary CAS: 921939-02-8
-
P/N:
CC62826DA
- UOM: EA
- UOM Qty: 1
|
|
Pentafluorophenyl 2-morpholino-1,3-thiazole-4-carboxylate; 97%; 250mg; F.W.: 380.29; C14H9F5N2O3S; M.P.: 118-119.5; Primary CAS: 921939-02-8
-
P/N:
CC62826CB
- UOM: EA
- UOM Qty: 1
|
|
ethyl 2-morpholino-1,3-thiazole-4-carboxylate; 97%; 5g; F.W.: 242.29; C10H14N2O3S; M.P.: 88.5-90; Primary CAS: 126533-95-7
-
P/N:
CC62823DE
- UOM: EA
- UOM Qty: 1
|
|
